Belongs to

• Solid Tumor Oncology Division

Types of Work

["2019"]

[[["Meeting Abstracts",235],["Journal Articles",209],["Reviews",7],["Editorials",5],["Research Letters",3],["Miscellaneous",2],["Book Sections",1]]]

[462]

Popular keywords

• adult
• aged
• article
• female
• gene mutation
• human
• humans
• major clinical study
• male
• priority journal

Recent Works

1. Beamion PANTUMOR-1: A phase II, multicenter, multicohort, open-label trial to evaluate the efficacy and safety of the oral HER2-selective tyrosine kinase inhibitor zongertinib for the treatment of HER2 -mutated or overexpressed/amplified solid tumors

   Meeting Abstract

   Schram, A. M.; Clay, T. D.; Prenen, H.; Park, J. J.; Lunger, L.; Hussain, J.; Maier, D.; Kitano, S.; Dumbrava, E. E.; Kim, H. D.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save
2. Restoration of the tumor suppressor function of Y220C-mutant p53 by rezatapopt, a small-molecule reactivator

   Journal Article

   Puzio-Kuter, A. M.; Xu, L.; McBrayer, M. K.; Dominique, R.; Li, H. H.; Fahr, B. J.; Brown, A. M.; Wiebesiek, A. E.; Russo, B. M.; Mulligan, C. L.; more...
   Cancer Discovery (2025)

   Fulltext@MSK | Save
3. The cold immunological landscape of ATM-deficient cancers

   Journal Article

   Sinha, S.; Ng, V.; Novaj, A.; Zhu, Y.; Yazaki, S.; Pei, X.; Derakhshan, F.; Pareja, F.; Setton, J.; Naulin, F.; more...
   Journal for ImmunoTherapy of Cancer (2025)

   Fulltext@MSK | Save